Expert Opinion on Therapeutic Targets

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials. The Editors welcome: Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development. Articles should not include clinical information including specific drugs and clinical trials. Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

《治疗靶点专家意见》是 MEDLINE 索引、同行评审、基于订阅的国际期刊，发表有关新型分子靶点的评论文章和原创论文，提供专家意见 关于未来药物开发的范围以及对药物发现的影响。 该杂志评估了分子、信号通路、受体和其他治疗靶点及其作为药物开发候选者的潜力。 该期刊的文章重点关注分子水平和早期临床前研究。文章不应包含临床信息，包括特定药物和临床试验。